Eiji Yukawa
- Pediatrics, Perinatology and Child Health top 1%
- Psychiatry and Mental health top 2%
- Oncology top 10%
- Pharmacology top 5%
- Pharmacology top 2%
- Co-authors
- Shun HiguchiToshinobu AoyamaShigehiro OhdoKohsuke MamiyaIchiro IeiriHideaki NinomiyaHideto ToHiroshi Takane
- Topics
- Pharmacological Effects and Toxicity Studies (37 papers)Epilepsy research and treatment (34 papers)Pharmaceutical studies and practices (25 papers)
- Cited by
- Pediatrics, Perinatology and Child HealthPsychiatry and Mental healthEndocrine and Autonomic Systems
- Journals
- Antimicrobial Agents and ChemotherapyJournal of Pharmacology and Experimental TherapeuticsLife Sciences
- Partner nations
- JapanUnited KingdomUnited States
In The Last Decade
Eiji Yukawa
99 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 105
- Pediatrics, Perinatology and Child Health 683
- Psychiatry and Mental health 500
- Oncology 314
- Pharmacology 248
- Pharmacology 238
Countries citing papers authored by Eiji Yukawa
This map shows the geographic impact of Eiji Yukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiji Yukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiji Yukawa more than expected).
Fields of papers citing papers by Eiji Yukawa
This network shows the impact of papers produced by Eiji Yukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiji Yukawa. The network helps show where Eiji Yukawa may publish in the future.
Co-authorship network of co-authors of Eiji Yukawa
This figure shows the co-authorship network connecting the top 25 collaborators of Eiji Yukawa. A scholar is included among the top collaborators of Eiji Yukawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiji Yukawa. Eiji Yukawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 18 | |
| 3 | 4 | |
| 4 | 23 | |
| 5 | 3 | |
| 6 | 19 | |
| 7 | 22 | |
| 8 | 13 | |
| 9 | 1 | |
| 10 | 22 | |
| 11 | Basis for dosing time-dependent changes in the antiviral activity of interferon-alpha in mice. | 23 |
| 12 | 12 | |
| 13 | 8 | |
| 14 | 17 | |
| 15 | 143 | |
| 16 | 55 | |
| 17 | 25 | |
| 18 | 18 | |
| 19 | 1 | |
| 20 | 2 |
About Eiji Yukawa
Eiji Yukawa is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Toxicology, having authored 99 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (37 papers), Epilepsy research and treatment (34 papers) and Pharmaceutical studies and practices (25 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (683 citations), Psychiatry and Mental health (500 citations) and Endocrine and Autonomic Systems (203 citations). Eiji Yukawa has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Shun Higuchi, Toshinobu Aoyama, Shigehiro Ohdo, Kohsuke Mamiya, Ichiro Ieiri, Hideaki Ninomiya, Hideto To, Hiroshi Takane, Shigeyuki Nakano and Satoru Koyanagi. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.